A detailed history of Mackenzie Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,288,977 shares of MRK stock, worth $220 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
2,288,977
Previous 2,339,106 2.14%
Holding current value
$220 Million
Previous $290 Million 10.24%
% of portfolio
0.39%
Previous 0.46%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $5.57 Million - $6.47 Million
-50,129 Reduced 2.14%
2,288,977 $260 Million
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $18.6 Million - $19.9 Million
149,979 Added 6.85%
2,339,106 $290 Million
Q1 2024

May 10, 2024

BUY
$113.24 - $131.95 $22 Million - $25.6 Million
193,843 Added 9.72%
2,189,127 $289 Million
Q4 2023

Jan 30, 2024

BUY
$100.18 - $109.02 $30 Million - $32.6 Million
299,077 Added 17.63%
1,995,284 $218 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $6.79 Million - $7.54 Million
-65,907 Reduced 3.74%
1,696,207 $175 Million
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $84.3 Million - $91.8 Million
-775,785 Reduced 30.57%
1,762,114 $203 Million
Q1 2023

Apr 24, 2023

BUY
$102.94 - $114.86 $4.84 Million - $5.4 Million
47,005 Added 1.89%
2,537,899 $270 Million
Q4 2022

Feb 14, 2023

BUY
$87.44 - $112.11 $1.1 Million - $1.4 Million
12,531 Added 0.51%
2,490,894 $276 Million
Q3 2022

Oct 07, 2022

BUY
$84.53 - $94.96 $8.45 Million - $9.49 Million
99,935 Added 4.2%
2,478,363 $213 Million
Q2 2022

Aug 10, 2022

BUY
$83.49 - $94.64 $19.2 Million - $21.8 Million
230,261 Added 10.72%
2,378,428 $217 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $180,834 - $202,704
2,460 Added 0.11%
2,148,167 $176 Million
Q4 2021

Feb 14, 2022

BUY
$72.28 - $90.54 $11.6 Million - $14.5 Million
160,345 Added 8.08%
2,145,707 $164 Million
Q3 2021

Nov 08, 2021

BUY
$71.68 - $78.83 $5.21 Million - $5.73 Million
72,702 Added 3.8%
1,985,362 $149 Million
Q2 2021

Aug 11, 2021

SELL
$70.31 - $77.77 $2.88 Million - $3.19 Million
-40,979 Reduced 2.1%
1,912,660 $149 Million
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $14 Million - $16.5 Million
-203,456 Reduced 9.43%
1,953,639 $151 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $10.7 Million - $11.9 Million
-149,471 Reduced 6.48%
2,157,095 $176 Million
Q3 2020

Nov 13, 2020

BUY
$73.18 - $82.95 $33.5 Million - $37.9 Million
457,228 Added 24.72%
2,306,566 $191 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $574,275 - $653,460
-8,155 Reduced 0.44%
1,849,338 $136 Million
Q1 2020

May 14, 2020

BUY
$63.36 - $87.82 $34.1 Million - $47.3 Million
538,634 Added 40.84%
1,857,493 $136 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $9.61 Million - $10.8 Million
123,918 Added 10.37%
1,318,859 $120 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $802,187 - $874,413
10,544 Added 0.89%
1,194,941 $101 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $49.2 Million - $57.5 Million
705,176 Added 147.15%
1,184,397 $99.3 Million
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $39.5 Million - $45 Million
-567,481 Reduced 54.22%
479,221 $39.9 Million
Q4 2018

Feb 06, 2019

SELL
$65.24 - $75.71 $10.9 Million - $12.7 Million
-167,694 Reduced 13.81%
1,046,702 $80 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $38.8 Million - $45.6 Million
-672,127 Reduced 35.63%
1,214,396 $86.1 Million
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $185 Million - $218 Million
-3,643,055 Reduced 65.88%
1,886,523 $115 Million
Q1 2018

May 14, 2018

SELL
$50.96 - $59.23 $21 Million - $24.4 Million
-411,576 Reduced 6.93%
5,529,578 $301 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $306 Million - $365 Million
5,923,357 Added 33282.9%
5,941,154 $334 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $37,020 - $39,835
631 Added 3.68%
17,797 $1.14 Million
Q2 2017

Aug 14, 2017

BUY
N/A
17,166
17,166 $1.1 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.